Aurigene Pharmaceutical Services Ltd., a global contract research, development, and manufacturing services organization (CRDMO), and Vipergen ApS, a niche small-molecule drug discovery service provider specialized in DNA encoded library (DEL) technologies, have partnered to co-market and offer DEL screening technologies to global customers as a standalone service or as an integrated drug discovery service.
In a bid to enhance healthcare provisions in the Republic of Belarus, the Pharmaceuticals Holding Company BELPHARMPROM, under the Ministry of Health, has reached out to Indian pharmaceutical companies for collaboration. This move aims to address the demand for essential medicines and explore opportunities for the localization of finished dosage forms (FDF).
The Subject Expert Committee (SEC), that advises the Central drug regulator regarding clinical trials and approvals of drugs, has recommended for grant of permission to Dr Reddy's Laboratories to import and market cancer drug toripalimab 240 mg solution for infusion with waiver of local phase III clinical trial, subject to conditions.
This initiative marks a significant step towards streamlining non-prescription drug regulations. A government-appointed committee is contemplating the idea of making commonly used drugs like cough and cold medicines, antacids, and fever-reducing drugs available at general stores in India.
The conflict in the Middle East could dent India's pharma exports if it escalates, industry experts say. While exports have not been affected so far, the next few days are crucial because, if there is serious escalation in the conflict, it could impact the whole Middle East and North Africa (MENA) region
HYDERABAD, April 18 (Reuters) - Indian drugmaker Biocon (BION.NS), opens new tab, looking to grab a piece of the exploding weight-loss drug market as early as possible, is developing its own version of Novo Nordisk's (NOVOb.CO), opens new tab wildly popular Wegovy and is prepared to conduct a clinical trial next year if needed, the CEO told Reuters.
Jubilant Pharmova's wholly owned subsidiary Jubilant Pharma, today announced that its subsidiary Jubilant Generics (JGL) received a communication from the USFDA through which the regulatory agency intimated that pursuant to its January 25 to February 2, 2024 audit of JGL's Solid dosage manufacturing facility at Roorkee
Dräger, a global leader in medical and safety technology has launched Vista 300 in India, a ground-breaking patient monitoring system designed to streamline information flow across hospital departments.